Latest News

Thursday, November 16, 2017 | Miscellaneous, Bausch+Lomb

Bausch + Lomb Reports Over 1 Million Units of Contact Lens Materials Recycled on First Anniversary of One By One Recycling Program

Bausch + Lomb announced on "America Recycles Day" that its exclusive ONE by ONE recycling program has recycled a combined total of more than one million used contact lenses, blister packs, a…

Read the full story

Wednesday, November 15, 2017 | Management/Leadership, Aerpio Therapeutics

Aerpio Pharmaceuticals Announces Appointment of Michael Rogers as Chief Financial Officer

Aerpio Pharmaceuticals announced that Michael Rogers has been appointed Chief Financial Officer effective as of November 15, 2017. Mr. Rogers has more than 25 years of experience in the biopharmaceuti…

Read the full story

Wednesday, November 15, 2017 | Medical Studies

Report: Global Ophthalmic Drugs Market Expected to Reach $42,663 Million by 2023

The global ophthalmic drugs market was valued at $29,613 million in 2016, and is projected to reach $42,663 million by 2023, growing at a CAGR of 5.3% from 2017 to 2023. The retinal disorders segment …

Read the full story

Wednesday, November 15, 2017 | Medical Studies

Diabetic Macular Edema Vastly Undertreated, Real-World Data Suggest

Most patients with newly diagnosed diabetic macular edema (DME) are inadequately treated, according to findings from the American Academy of Ophthalmology's IRIS Registry, as reported in Medscape.…

Read the full story

Wednesday, November 15, 2017 | Medical Studies, American Academy of Ophthalmology

Annoyed by Floating Specks in Your Vision? You May Soon be Able to Zap Them Away

Millions of people who put up with seeing annoying specks drift through their field of vision may now have a safe, high-tech solution to their problem. A study of patients who had laser treatment to v…

Read the full story

Tuesday, November 14, 2017 | Medical Studies, American Academy of Ophthalmology

Stem Cell Therapy Shows Promise for Common Cause of Blindness

Results from two early clinical trials show that it may be possible to use human embryonic stem cells as treatment for the dry form of macular degeneration, according to presentations given at AAO 201…

Read the full story

Tuesday, November 14, 2017 | Medical Studies, American Academy of Ophthalmology

Study: Hormone Replacement Therapy May Protect Against Eye Disease

Women who took estrogen-only hormone replacement therapy after ovary removal had a lower risk of developing glaucoma, according to research presented at AAO. This research, which was conducted at…

Read the full story

Tuesday, November 14, 2017 | Earnings & Financials

Q BioMed Announces Funding to Technology Partner Mannin Research to Expand Product Pipeline

Q BioMed' collaborative research partner and licensor, Mannin Research, has received R&D funding from the National Research Council of Canada Industrial Research Assistance Program (…

Read the full story

Tuesday, November 14, 2017 | Medical Studies, American Academy of Ophthalmology

AAO: Wouldn't it be Great if Eyedrops Didn't Spill Out of Your Eyes?

A new kind of eyedropper can deliver tiny droplets of medication, treating the eye more precisely than traditional eyedroppers, while reducing waste and avoiding dangerous side effects. According to r…

Read the full story

Tuesday, November 14, 2017 | Medical Studies, American Academy of Ophthalmology

Another Reason to Exercise: Protecting Your Sight

People who engage in moderate to vigorous physical activity may be able to significantly lower their risk of glaucoma. Researchers from the University of California, Los Angeles reported a 73 per…

Read the full story

Tuesday, November 14, 2017 | Product Releases, Bausch+Lomb

Bausch + Lomb Launches Expanded Parameters of Bausch + Lomb Ultra for Astigmatism Contact Lenses

Bausch + Lomb announced the launch of expanded parameters of Bausch + Lomb ULTRA for Astigmatism contact lenses. This expansion will extend the lens parameter offering to +6.00D to -9.00D in 0.25D ste…

Read the full story

Tuesday, November 14, 2017 | Product Releases

MediCapture Rolls Out New 4K Ultra HD Medical Video Recorder, the Medicap MVR Lite 4K

MediCapture announced that the MediCap MVR Lite 4K, its new 4K Ultra HD recorder, is now commercially available. With four times the picture resolution of HD medical video recorders, the MediCap MVR L…

Read the full story

Monday, November 13, 2017 | Medical Studies, American Academy of Ophthalmology

World's Largest Clinical Specialty Database Yields Critical Insights to Advance Ophthalmic Patient Care

The American Academy of Ophthalmology announced key milestones and clinical insights from studies powered by its clinical database. The IRIS Registry (Intelligent Research In Sight) has amassed more t…

Read the full story

Monday, November 13, 2017 | Clinical Trials, Clearside Biomedical

Clearside Biomedical’s Phase 1/2 Open-Label Clinical Trial of CLS-TA With and Without Eylea in DME Presented at AAO

Charles C. Wykoff, MD, PhD, presented preliminary results from an exploratory clinical trial (the HULK trial) of CLS-TA, Clearside’s proprietary suspension formulation of the corticosteroid tria…

Read the full story

Monday, November 13, 2017 | Management/Leadership, Kala Pharmaceuticals

Kala Pharmaceuticals Appoints Todd Bazemore as Chief Operating Officer

Kala Pharmaceuticals announced the appointment of Todd Bazemore as Chief Operating Officer of the company. He will report directly to Mark Iwicki, Chairman and Chief Executive Officer of Kala Pharmace…

Read the full story
Load More
 Stock Price  Change 
 ADVM $3.00  0.00% 
 Aerie Pharmaceuticals, Inc. $61.28  -0.20% 
 Akorn, Inc. $32.64  1.05% 
 Alimera Sciences, Inc. $1.26  1.61% 
 Allergan $173.63  1.73% 
 Applied Genetic Technologies $3.95  3.95% 
 Bayer $32.22  0.06% 
 Can-Fite Biopharma $1.43  1.42% 
 Carl Zeiss Meditec $46.04  -6.43% 
 Clearside Biomedical $7.23  3.14% 
 Cooper Companies, Inc. $242.38  0.95% 
 Eleven Biotherapeutics $0.69  4.32% 
 Escalon Medical Corp. $0.20  28.95% 
 Essilor International $107.65  -0.23% 
 Glaukos $25.30  -0.20% 
 Imprimis Pharmaceuticals, Inc. $1.80  1.69% 
 Inotek Pharmaceuticals $2.44  2.95% 
 IRIDEX Corporation $8.58  11.43% 
 Johnson & Johnson $138.25  -0.07% 
 Merck & Company, Inc. $54.38  0.20% 
 NicOx $8.88  -8.22% 
 NovaBay Pharmaceuticals, Inc. $4.30  -3.37% 
 Novartis AG Common Stock $85.14  1.02% 
 Ocular Therapeutix $4.13  -3.95% 
 Ophthotech Corporation $3.43  1.18% 
 Quantel $6.40  1.11% 
 Regeneron $384.86  0.11% 
 Roche $31.72  2.09% 
 Second Sight Medical Products $1.21  6.50% 
 Shire $147.85  2.09% 
 Spark Therapeutics, Inc. $74.16  1.92% 
 STAAR Surgical Company $16.25  -2.69% 
 TearLab Corporation $0.71  0.00% 
 Thrombogenics $4.56  -1.28% 
 Valeant Pharmaceuticals $16.56  3.56% 
 Xoma $28.27  12.72%